Challenges of fragment screening

نویسنده

  • Diane Joseph-McCarthy
چکیده

Fragment-based screening for lead generation has seen tremendous growth and success in the last few years. Furthermore, the careful design of fragment libraries has ensured both that the coverage of chemical space is as great as possible and also that the included fragments have desirable physical properties. This particular effort has thus enhanced the advantages of a fragment-based approach. Other technological advances and applications have increased the speed of the process, resulting in more successful case studies being presented. Nonetheless challenges still remain. Weak fragment hits are often overlooked in favor of more potent HTS hits that may have poorer physical properties and ligand efficiencies. The timelines necessary to realize success with fragment-based screens can be long relative to other lead generation approaches, since fragment hits need to be given sufficient consideration and may require more cycles for optimization. A robust system for crystallography, which can be difficult to develop, can also dramatically affect the final outcome of a fragment-based lead generation campaign by enabling the determination of high-resolution complex structures that can serve as starting points for structure-based design. Active research is helping to address these challenges. Computational approaches that can aid in the optimization process either through growing or linking of fragments continue to be developed and can play a significant role in reducing the time required for improving the potency of an initial fragment lead. Methods aimed at exploiting fragment hits for uses other than scaffold generation are also being established to take full advantage of this information as well as any associated structural information available for a project. For example, fragment hits can be merged onto an HTS scaffold during the lead optimization process. In addition, for a given target, potential pharmacophores can be derived from fragment hits and later used for virtual screening of databases to enable scaffold hopping. Fragment positioning methods such as GRID [1], MCSS [2–4], SPROUT [5], MUSIC [6], LUDI [7, 8], and Superstar [9] have been in use for over two decades now and are typically employed during the early stage of lead optimization. These methods determine energetically favorable binding site positions for various functional group types or chemical fragments based on molecular mechanics or knowledge-based potentials. ‘‘Hot spots’’ can be calculated for a wide range of functional groups in a given target binding site/region. Such target-derived pharmacophoric points can also be used to guide docking calculations to more finely sample the relevant regions of a binding site (e.g., [10, 11]) or to perform pharmacophore searches of large databases. Caveat [12] and HOOK [13] were among the first ‘‘fragment-linking’’ computational approaches developed in the early 1990s. Newer generation computational methods continue to be developed (e.g., Re-core [14], Allegrow (Boston De Novo Design, Boston, MA, 2009), Confirm [15], MED-SuMo [16], and pharmacophore modeling for scaffold replacement in MOE (Chemical Computing Group, Montreal, Canada, 2009)) and successful uses of these newer programs are being reported. Increasingly, standard molecular docking programs are being utilized to screen large databases of small molecules to created target-focused fragment sets for experimental testing either in a high-concentration biochemical assay or by biophysical means such as NMR, Biacore, mass spectrometry, or X-ray crystallography. Focused fragment sets D. Joseph-McCarthy (&) Infection Computational Sciences, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA e-mail: [email protected]

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Fragment based drug design: from experimental to computational approaches.

Fragment based drug design has emerged as an effective alternative to high throughput screening for the identification of lead compounds in drug discovery in the past fifteen years. Fragment based screening and optimization methods have achieved credible success in many drug discovery projects with one approved drug and many more compounds in clinical trials. The fragment based drug design star...

متن کامل

Yeast Two Hybrid cDNA Screening of Arabidopsis thaliana for SETH4 Protein Interaction

SETH4 coding sequence with 2013 bp is a member of gene family expressed in gametophytic tissues of Arabidopsis thaliana. This fragment was PCR amplified using Kod Hi Fi DNA polymerase enzyme. This fragment was cloned into pGBKT7 bate vector and transformed E. coli DH5? cells containing vector were selected on LB medium containing Kanamycin. Finally, pGBKT7-SETH4 bate was transformed into yeast ...

متن کامل

Is NMR Fragment Screening Fine-Tuned to Assess Druggability of Protein–Protein Interactions?

Modulation of protein-protein interactions (PPIs) with small molecules has been hampered by a lack of lucid methods capable of reliably identifying high-quality hits. In fragment screening, the low ligand efficiencies associated with PPI target sites pose significant challenges to fragment binding detection. Here, we investigate the requirements for ligand-based NMR techniques to detect rule-of...

متن کامل

Integrated biophysical approach to fragment screening and validation for fragment-based lead discovery.

In fragment-based drug discovery, the weak affinities exhibited by fragments pose significant challenges for screening. Biophysical techniques are used to address this challenge, but there is no clear consensus on which cascade of methods is best suited to identify fragment hits that ultimately translate into bound X-ray structures and provide bona fide starting points for synthesis. We have be...

متن کامل

Multiprotein Systems As Targets for Drug Discovery: Opportunities and Challenges

In the past twenty years structural biology has come to play a major role in lead optimization and target identification in the process of drug discovery. Only recently, however, has the development of highthroughput methods of structure determination provided a powerful approach to the screening of fragment binding so that structural biology can now contribute directly to lead discovery. Most ...

متن کامل

Structure-based virtual fragment screening for ligands of the G protein-coupled histamine H4 receptor

The determination of the first set of crystal structures for the family of G protein-coupled receptors (GPCRs) has opened up new opportunities in structure-based ligand discovery for this pharmaceutically relevant protein family. We have explored the possibilities and challenges of structure-based virtual fragment screening (SBVFS) against the histamine H4 receptor (H4R), a key player in inflam...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Journal of computer-aided molecular design

دوره 23 8  شماره 

صفحات  -

تاریخ انتشار 2009